Early effects of lipopolysaccharide on cytokine release, hemodynamic and renal function in newborn piglets

Neonatology

Volumn 93, Issue 2, 2008, Pages 106-112

  John, Eunice ^a   Pais, Priya ^a   Furtado, Nicholas ^a   Chin, Anthony ^a   Radhakrishnan, Jayant ^a   Fornell, Linda ^a   Lumpaopong, Adisorn ^a   Beier, Ulf H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Early cytokine response; Endotoxin; Gram negative sepsis; Renal function

Indexed keywords

CYTOKINE; ENDOTHELIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MICROSPHERE; NITRATE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; CYSTOSTOMY; CYTOKINE RELEASE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; GRAM NEGATIVE SEPSIS; HEART LEFT VENTRICLE; HEART RATE; IMMUNE RESPONSE; JUGULAR VEIN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PIGLET; PRIORITY JOURNAL; URINE VOLUME; VEIN CATHETERIZATION;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEART RATE; INTERLEUKIN-1BETA; KIDNEY; LIPOPOLYSACCHARIDES; NITRIC OXIDE; SENSITIVITY AND SPECIFICITY; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE;

ANIMALIA; NEGIBACTERIA;

EID: 38949094907     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000107352     Document Type: Article

References (40)

1. Larson E, Cimiotti JP, Haas J, Nesin M, Allen A, Della-Latta P, Saiman L: Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units. Pediatr Crit Care Med 2005;6:457-461.
2. Wei S, Chiu HH, Hung KC, Wang JH, Su BH, Lin HC, Lin TW, Lin HC: Epidemiologic trends in nosocomial bacteremia in a neonatal intensive care unit. J Microbiol Immunol Infect 2005;38:283-288.
3. Stoll B, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hale E;National Institute of Child Health and Human Development: Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gramnegative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005;24:635-639.
4. Heyman S, Darmon D, Goldfarb M, Bitz H, Shina A, Rosen S, Brezis M: Endotoxin-induced renal failure. I. A role for altered renal microcirculation. Exp Nephrol 2000;8:266-274.
5. Stapleton F, Jones DP, Green RS: Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1987;1:314-320.
6. Zhou H, Ding GF, Liu W, Wang LX, Lu YL, Cao HW, Zheng J: Lipopolysaccharide could be internalized into human peripheral blood mononuclear cells and elicit TNF-alpha release, but not via the pathway of toll-like receptor 4 on the cell Surface. Cell Mol Immunol 2004;1:373-377.
7. Nikaido H: Outer membrane of Salmonella typhimurium . Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta 1976;433:118-132.
8. Hopkin D: Frapper fort ou frapper doucement: a gram-negative dilemma. Lancet 1978;2:1193-1194.
9. Cohen J: The immunopathogenesis of sepsis. Nature 2002;420:885-891.
10. Gerdes J, Polin R: Early diagnosis and treatment of neonatal sepsis. Indian J Pediatr 1998;65:63-78.
11. Doellner H, Arntzen KJ, Haereid PE, Aag S, Austgulen R: Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr 1998;132:295-299.
12. Huang S, Tang RB, Chen SJ, Chung RL: Serum interleukin-6 level as a diagnostic test in children with sepsis. J Chin Med Assoc 2003;66:523-527.
13. Nguyen L, Lievano G, Radhakrishnan J, Fornell LC, Jacobson G, John EG: Renal effects of low to moderate doses of dopamine in newborn piglets. J Pediatr Surg 1999;34:996-999.
14. Ishise S, Pegram BL, Yamamoto J, Kitamura Y, Frohlich ED: Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol 1980;239:H443-H449.
15. Tsuchiya M, Walsh GM, Frohlich ED: Systemic hemodynamic effects of microspheres in conscious rats. Am J Physiol 1977;233:H617-H621.
16. Green L, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131-138.
17. Rangel-Frausto M: Sepsis: still going strong. Arch Med Res 2005;36:672-681.
18. Wheeler A, Hardie WD, Bernard GR: The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep. Am Rev Respir Dis 1992;145:632-639.
19. van der Poll T, Coyle SM, Levi M, Jansen PM, Dentener M, Barbosa K, Buurman WA, Hack CE, ten Cate JW, Agosti JM, Lowry SF: Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 1997;89:3727-3734.
20. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA: Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 1996;335:311-315.
21. Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997;25:1095-1100.
22. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL: Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-783.
23. van der Poll T, van Deventer SJ: Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 1999;13:413-426, ix.
24. Lirk P, Hoffmann G, Rieder J: Inducible nitric oxide synthase - time for reappraisal. Curr Drug Targets Inflamm Allergy 2002;1:89-108.
25. Fareed D, Iqbal O, Tobu M, et al: Blood levels of nitric oxide, C-reactive protein, and tumor necrosis factor-alpha are upregulated in patients with malignancy-associated hypercoagulable state: pathophysiologic implications. Clin Appl Thromb Hemost 2004;10:357-364.
26. Yamada M, Ichikawa T, Ii M, et al: Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex- 1-ene-1-carboxylate. J Med Chem 2005;48:7457-7467.
27. Enkhbaatar P, Murakami K, Traber LD, et al: The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 2006;25:522-527.
28. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
29. Hickson-Bick DL, Jones C, Buja LM: The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. Shock 2006;25:546-552.
30. Kramer BW, Ikegami M, Jobe AH: Intratracheal endotoxin causes systemic inflammation in ventilated preterm lambs. Am J Respir Crit Care Med 2002;165:463-469.
31. Parker JL, Myers PR, Zhong Q, et al: Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia. Shock 1994;2:451-458.
32. Quinn JV, Slotman GJ: Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Crit Care Med 1999;27:2485-2494.
33. Solhaug MJ, Dong XQ, Adelman RD, Dong KW: Ontogeny of neuronal nitric oxide synthase, NOS I, in the developing porcine kidney. Am J Physiol Regul Integr Comp Physiol 2000;278:R1453-R1459.
34. Haynes WG, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852-854.
35. Naicker S, Bhoola KD: Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther 2001;90:61-88.
36. Schmidt C, Hocherl K, Bucher M: Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 2007;292:F804-F811.
37. Oishi R, Nonoguchi H, Tomita K, Marumo F: Endothelin-1 inhibits AVP-stimulated osmotic water permeability in rat inner medullary collecting duct. Am J Physiol 1991;261:F951-F956.
38. Knotek M, Rogachev B, Wang W, et al: Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001;59:2243-2249.
39. Yamaguchi N, Jesmin S, Zaedi S, et al: Timedependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 2006;27:2258-2270.
40. Iskit AB, Senel I, Sokmensuer C, Guc MO: Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock. Eur J Pharmacol 2004;506:83-88.